skip to main content
Idioma:

Osteoprotegerin and zoledronate bone effects during orthodontic tooth movement

Fernández-González, F. J. ; López-Caballo, J. L. ; Cañigral, A. ; Menéndez-Díaz, I. ; Brizuela, A. ; de Cos, F. J. ; Cobo, T. ; Vega, J. A.

Orthodontics & craniofacial research, 2016-02, Vol.19 (1), p.54-64 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
  • Título:
    Osteoprotegerin and zoledronate bone effects during orthodontic tooth movement
  • Autor: Fernández-González, F. J. ; López-Caballo, J. L. ; Cañigral, A. ; Menéndez-Díaz, I. ; Brizuela, A. ; de Cos, F. J. ; Cobo, T. ; Vega, J. A.
  • Assuntos: Animals ; bisphosphonate ; Bone Resorption - drug therapy ; Dentistry ; Male ; orthodontic anchorage ; Osteoclasts ; Osteoprotegerin ; periodontal ligament ; Rats ; Rats, Sprague-Dawley ; tooth movement ; Tooth Movement Techniques
  • É parte de: Orthodontics & craniofacial research, 2016-02, Vol.19 (1), p.54-64
  • Notas: istex:521681A0A1AB2E73373864A4FFB583B4AB268F80
    ark:/67375/WNG-XVTM1JL0-8
    ArticleID:OCR12115
    ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Structured Objectives To assess the effects of local delivery of recombinant fusion protein osteoprotegerin (OPG‐Fc) and bisphosphonate zoledronate on bone and periodontal ligament in a rat tooth movement model. Materials and methods Maxillary first molars of 36 male Sprague–Dawley rats were displaced mesially using a calibrated spring connected to an anterior mini‐screw. Two different drugs were used: a single dose of Zoledronate (16 μg) and a twice‐weekly dose of OPG‐Fc (5.0 mg/kg) were injected. Tooth movement was measured on scanned plaster casts. Structural and immunohistochemical analysis of the orthodontic‐induced changes in bone included receptor activator of nuclear factor ĸ (RANK), Runx, type 1 collagen, matrix metalloproteinases (MMPs) 2 and 9, tissue inhibitors of metalloproteinases (TIMPs) 1 and 2, and vimentin. Results Both groups showed a reduction in mesial molar displacement. Animals receiving OPG‐Fc demonstrated only 52%, 31%, and 21% of the total mesial molar displacement compared to control rats at 7, 14, and 21 days, respectively (*p < 0.001). For rats receiving zoledronate tooth displacement decreased significantly with 52%, 46% and 30%, respectively (*p < 0.001). At 14 and 21 days, OPG‐Fc group showed significantly less molar displacement than the zoledronate group (*p < 0.001). RANK, Runx, vimentin, MMP‐9 and tissues‐inhibitor metalloproteinase 1 immunoreactivity were reduced in zoledronate treated animals and even more in OPG treated animals. Conclusion Local delivery of OPG‐Fc or zoledronate inhibits bone resorption and therefore tooth movement. OPG‐Fc was more effective than zoledronate in blocking the action of osteoclasts.
  • Editor: England: Blackwell Publishing Ltd
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.